Publicaciones en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (5)

2011

  1. Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients

    Clinical Lung Cancer, Vol. 12, Núm. 5, pp. 320-327

  2. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer

    Journal of Thoracic Oncology, Vol. 6, Núm. 2, pp. 286-290

  3. Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

    Clinical and Translational Oncology, Vol. 13, Núm. 6, pp. 411-418

  4. The identification of KRAS mutations at codon 12 in plasma DNA is not a prognostic factor in advanced non-small cell lung cancer patients

    Lung Cancer, Vol. 72, Núm. 3, pp. 365-369

2008

  1. Retrospective analysis of the prognostic role of p16 protein inactivation in plasma in patients with locally advanced non-small cell lung cancer

    Lung Cancer, Vol. 61, Núm. 1, pp. 104-108